ADIM
MORF

Alpha DNA Investment Management’s Morphic Holding, Inc. Common Stock MORF Stock Holding History

Alpha DNA Investment Management’s Portfolio MORF Stock Details MORF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-48
Closed -$3K – 695
2021
Q1 		$3K Buy
+48
New +$2.2K ﹤0.01% 531

Other funds holding MORF

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Alpha DNA Investment Management's MORF Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of Morphic Holding, Inc. Common Stock (MORF) in Q2 2021, closing a stake of 48 shares — an estimated $3K sold.

Alpha DNA Investment Management first reported a position in MORF in Q1 2021 and held it in 1 quarter. The position peaked at $3K in Q1 2021. 106 funds tracked by Wall St. Rank hold MORF as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining Morphic Holding, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 48 Morphic Holding, Inc. Common Stock shares in Q2 2021, an estimated $3K.
  • Alpha DNA Investment Management first reported a position in Morphic Holding, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Alpha DNA Investment Management's Morphic Holding, Inc. Common Stock position peaked at $3K in Q1 2021.
  • 106 funds tracked by Wall St. Rank held Morphic Holding, Inc. Common Stock as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.